Annual Retained Earnings:
-$148.92M+$673.73M(+81.90%)Summary
- As of today, AGIO annual retained earnings is -$148.92 million, with the most recent change of +$673.73 million (+81.90%) on December 31, 2024.
- During the last 3 years, AGIO annual retained earnings has risen by +$89.84 million (+37.63%).
- AGIO annual retained earnings is now -176.12% below its all-time high of -$53.94 million, reached on December 31, 2011.
Performance
AGIO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$350.23M-$112.02M(-47.03%)Summary
- As of today, AGIO quarterly retained earnings is -$350.23 million, with the most recent change of -$112.02 million (-47.03%) on June 30, 2025.
- Over the past year, AGIO quarterly retained earnings has increased by +$650.08 million (+64.99%).
- AGIO quarterly retained earnings is now -1235.28% below its all-time high of $30.85 million, reached on March 31, 2021.
Performance
AGIO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AGIO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +81.9% | +65.0% |
| 3Y3 Years | +37.6% | +17.7% |
| 5Y5 Years | +90.2% | +78.7% |
AGIO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +81.9% | -568.4% | +65.0% |
| 5Y | 5-Year | at high | +91.9% | -1235.3% | +81.0% |
| All-Time | All-Time | -176.1% | +91.9% | -1235.3% | +81.0% |
AGIO Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$350.23M(-47.0%) |
| Mar 2025 | - | -$238.21M(-60.0%) |
| Dec 2024 | -$148.92M(+81.9%) | -$148.92M(-184.2%) |
| Sep 2024 | - | -$52.40M(+94.8%) |
| Jun 2024 | - | -$1.00B(-10.6%) |
| Mar 2024 | - | -$904.20M(-9.9%) |
| Dec 2023 | -$822.65M(-74.8%) | -$822.65M(-13.2%) |
| Sep 2023 | - | -$726.71M(-14.4%) |
| Jun 2023 | - | -$635.38M(-15.2%) |
| Mar 2023 | - | -$551.58M(-17.2%) |
| Dec 2022 | -$470.56M(-97.1%) | -$470.56M(+7.2%) |
| Sep 2022 | - | -$507.09M(-19.2%) |
| Jun 2022 | - | -$425.34M(-27.5%) |
| Mar 2022 | - | -$333.53M(-39.7%) |
| Dec 2021 | -$238.76M(+87.0%) | -$238.76M(-65.7%) |
| Sep 2021 | - | -$144.13M(-160.3%) |
| Jun 2021 | - | -$55.37M(-279.5%) |
| Mar 2021 | - | $30.85M(+101.7%) |
| Dec 2020 | -$1.84B(-21.6%) | -$1.84B(-5.6%) |
| Sep 2020 | - | -$1.75B(-6.0%) |
| Jun 2020 | - | -$1.65B(-5.8%) |
| Mar 2020 | - | -$1.56B(-2.7%) |
| Dec 2019 | -$1.52B(-37.2%) | -$1.52B(-7.2%) |
| Sep 2019 | - | -$1.41B(-8.1%) |
| Jun 2019 | - | -$1.31B(-9.2%) |
| Mar 2019 | - | -$1.20B(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -$1.10B(-38.4%) | -$1.10B(-9.1%) |
| Sep 2018 | - | -$1.01B(-10.3%) |
| Jun 2018 | - | -$918.17M(-8.1%) |
| Mar 2018 | - | -$849.43M(-6.4%) |
| Dec 2017 | -$798.06M(-65.2%) | -$798.06M(-12.4%) |
| Sep 2017 | - | -$709.78M(-12.2%) |
| Jun 2017 | - | -$632.64M(-15.1%) |
| Mar 2017 | - | -$549.56M(-13.7%) |
| Dec 2016 | -$483.15M(-69.7%) | -$483.15M(-13.2%) |
| Sep 2016 | - | -$426.67M(-17.3%) |
| Jun 2016 | - | -$363.83M(-18.2%) |
| Mar 2016 | - | -$307.88M(-8.1%) |
| Dec 2015 | -$284.68M(-70.5%) | -$284.68M(-16.6%) |
| Sep 2015 | - | -$244.06M(-19.8%) |
| Jun 2015 | - | -$203.80M(-18.6%) |
| Mar 2015 | - | -$171.91M(-3.0%) |
| Dec 2014 | -$166.95M(-47.2%) | -$166.95M(-19.0%) |
| Sep 2014 | - | -$140.28M(+2.6%) |
| Jun 2014 | - | -$143.99M(-14.6%) |
| Mar 2014 | - | -$125.69M(-10.8%) |
| Dec 2013 | -$113.44M(-53.2%) | -$113.44M(-12.3%) |
| Sep 2013 | - | -$101.06M(-12.4%) |
| Jun 2013 | - | -$89.89M(-10.6%) |
| Mar 2013 | - | -$81.27M(-9.8%) |
| Dec 2012 | -$74.04M(-37.3%) | -$74.04M |
| Dec 2011 | -$53.94M | - |
FAQ
- What is Agios Pharmaceuticals, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. annual retained earnings year-on-year change?
- What is Agios Pharmaceuticals, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
What is Agios Pharmaceuticals, Inc. annual retained earnings?
The current annual retained earnings of AGIO is -$148.92M
What is the all-time high annual retained earnings for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high annual retained earnings is -$53.94M
What is Agios Pharmaceuticals, Inc. annual retained earnings year-on-year change?
Over the past year, AGIO annual retained earnings has changed by +$673.73M (+81.90%)
What is Agios Pharmaceuticals, Inc. quarterly retained earnings?
The current quarterly retained earnings of AGIO is -$350.23M
What is the all-time high quarterly retained earnings for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high quarterly retained earnings is $30.85M
What is Agios Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
Over the past year, AGIO quarterly retained earnings has changed by +$650.08M (+64.99%)